Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods for delivering compounds into a cell

a cell and compound technology, applied in the field of intracellular delivery, can solve the problems of high cost, low efficiency of transfection (delivery of genetic material into cells) and subsequent gene expression, and difficulty in gene expression

Inactive Publication Date: 2005-04-14
IMARX PHARM CORP
View PDF8 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a method for delivering a compound into a cell by administering a composition containing the compound and an organic halide to the cell. This method can also be used to treat a patient by administering the compound or a composition containing it, along with an organic halide, and applying ultrasound. The invention also includes a method for effecting the expression of a nucleotide sequence in a cell by administering a nucleotide sequence or a composition containing it, and applying ultrasound. The compositions may also contain a carrier. The technical effects of this invention include improved delivery of compounds into cells and increased effectiveness of treatments and diagnostics."

Problems solved by technology

Conventional interventional methods of delivery of compounds into cells have proved difficult in view of the need for the compounds to pass through the cell membrane, cell wall, and nuclear membrane.
However, one drawback of this method is that the resultant efficiency of transfection (delivery of the genetic material into the cells) and subsequent gene expression has been very low.
Improved transfection has been attained using viral vectors, e.g., adenovirus and retrovirus, but again, difficulties with gene expression have persisted.
In addition, substantial concerns regarding antigenicity and the potential of mutant viruses and other possible deleterious effects exist.
However, while gene guns have resulted in gene expression in culture systems, they have not worked well in vivo.
Furthermore, the blast of heavy metal particles may cause damage to the cells and may result in the introduction of undesirable foreign materials, e.g. gold particle fragments, into the cells.
However, electroporation may damage cells, and furthermore has not been shown to be highly effective in vivo.
The energy and frequency ranges are typically painful to a patient and thus usually require patient sedation.
Lithotripsy machines are large and bulky and are typically cost prohibitive.
Zhang et al. do not disclose the ultrasound frequency.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for delivering compounds into a cell
  • Methods for delivering compounds into a cell
  • Methods for delivering compounds into a cell

Examples

Experimental program
Comparison scheme
Effect test

example 1

Effect of Ultrasound on the Temperature of an Aqueous-Based Medium in Culture Plate Well Phantoms and on Cell Viability

The first phase of evaluating the effect of ultrasound was to measure the amount of heating caused by the ultrasound energy. The experimental protocol was designed to evaluate the heating in an individual well of a 6 well culture plate while exposed to ultrasound. Ultrasound was applied for 30 seconds to each well and the relationship between energy and heating is shown in Table 2 below.

TABLE 2Temperature increaseTemperature increaseEnergyat 10% Duty Cycleat 100% Duty Cycle0.5 W / cm2  0° C.0.5° C.1 W / cm20° C.1.5° C.2 W / cm20.5° C.  2.9° C.

A follow-up experiment was carried out to assay the cell viability after ultrasound exposure. A cell proliferation kit using sodium 3′-[1-(phenylamino-carbonyl)3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene sulfonic acid hydrate (XTT, Boehringer-Mannheim, Indianapolis, Ind.) as the cell viability indicator was carried out to eva...

example 2

Effect of Ultrasound on Gene Expression in Cell Culture

Materials and Methods for Transfection and Measurement of Gene Expression

The DNA plasmid used was pCAT Control (GenBank accession number X65321) (Promega, Madison, Wis.) (see FIG. 3).

The plasmid was transformed into DH5-αEscherichia coli competent cells (Life Technologies, Gaithersburg, Md.). The cells were plated on LB agar plates (Bio 101, Vista, Calif.) that contained ampicillin (Boehringer Mannheim Biochemicals (BMB), Indianapolis, Ind.). Resistant colonies were selected, grown up and a Wizard mini-prep (Promega) plasmid DNA extraction was carried out. Plasmid DNA was cut with restriction enzyme EcoRI (BMB) and run on a 1% agarose gel (BMB). After fragments were evaluated for size, the remaining culture was used to start a large culture and a Wizard maxi-prep was carried out to produce DNA for transfection. The DNA was quantified using a Hoefer TKO-100 mini-DNA fluorometer. The DNA was then ready for use in transfectio...

example 3

Application Using DNA with a Lipid Carrier and a Cavitator

The cells and the DNA / lipid complex were prepared as in Example 2. Six well plates were seeded with HeLa cells and filled with 16 ml of media as in Example 2. The lipid added was increased to 135 μg to allow for the increase in volume and the DNA was also increased to 22.5 μg per well. One hour after the complex was added, 100 μl of a liposome comprised of the lipids dipalmitoylphosphatidylcholine (DPPC), dipalmitoylphosphatidylethanolamine coupled to polyethylene glycol 5000 (DPPE-PEG5000), and dipalmitoylphosphatidic acid (DPPA), in a ratio of about 82%:8%: 10% (mole %) was added to each well. The DPPE-PEG5000 was comprised of DPPE and PEG5000 in a ratio of about 20%:80% (weight %). PEG5000 refers to PEG having an average molecular weight of about 5000. In addition, a negative control was added which included cells grown up not transfected with CAT / lipid complex and without ultrasound treatment.

The six well plate was th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
frequencyaaaaaaaaaa
pressureaaaaaaaaaa
speedaaaaaaaaaa
Login to View More

Abstract

The present invention is directed, inter alia, to a method for delivering a compound into a cell comprising administering to the cell the compound to be delivered, an organic halide, and / or a carrier. Ultrasound may also be applied, if desired.

Description

FIELD OF THE INVENTION This invention relates to the field of intracellular delivery, in particular, to the use of organic halides and / or ultrasound to facilitate the delivery of a compound into a cell. BACKGROUND OF THE INVENTION Cells are the basic structural and functional units of all living organisms. All cells contain cytoplasm surrounded by a plasma, or cell, membrane. Most bacterial and plant cells are enclosed in an outer rigid or semi-rigid cell wall. The cells contain DNA which may be arranged in 1) a nuclear membrane or 2) free in cells lacking a nucleus. While the cell membrane is known to contain naturally occurring ion channels, compounds that are therapeutically advantageous to cells are usually too large to pass through the naturally occurring ion channels. Conventional interventional methods of delivery of compounds into cells have proved difficult in view of the need for the compounds to pass through the cell membrane, cell wall, and nuclear membrane. Molecular...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/127A61K41/00C12N15/09A61K45/08A61K47/02A61K47/18A61K47/30A61K47/42A61K48/00A61P3/10A61P7/00A61P9/10A61P11/00A61P21/00A61P31/18A61P35/00C12N5/10C12N15/87C12N15/88C12P21/02
CPCA61K9/1272A61K41/0028C12N15/88C12N15/87A61K48/00A61P11/00A61P21/00A61P31/18A61P35/00A61P7/00A61P9/10A61P3/10
Inventor UNGER, EVAN C.MCCREERY, THOMAS
Owner IMARX PHARM CORP